|
69
|
277
|
4lghA |
Crystal structure of 1nm-pp1 bound to analog-sensitive src kinase |
|
89
|
287
|
4l00A |
Crystal structure of the apo jak1 pseudokinase domain |
|
84
|
291
|
4k77A |
Jak1 kinase (jh1 domain) in complex with compound 6 |
|
76
|
266
|
4l7sA |
Kinase domain mutant of human itk in complex with an aminobenzothiazole inhibitor |
|
81
|
290
|
4k6zA |
The jak1 kinase domain in complex with compound 37 |
|
70
|
270
|
4lggA |
Structure of 3mb-pp1 bound to analog-sensitive src kinase |
|
88
|
271
|
4k9yA |
Focal adhesion kinase catalytic domain in complex with 1-[4-(6-amino-purin-9-yl)-phenyl]-3-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-urea |
|
94
|
286
|
4l01A |
Crystal structure of the v658f apo jak1 pseudokinase domain |
|
129
|
448
|
4k11A |
The structure of 1na in complex with src t338g |
|
5
|
59
|
4le9A |
Crystal structure of a chimeric c-src-sh3 domain |
|
81
|
275
|
4kabA |
Focal adhesion kinase catalytic domain in complex with 3-methyl-1,4-dihydro-pyrazolo[4,5-c]pyrazole |
|
83
|
270
|
4k8aA |
Fragment-based discovery of focal adhesion kinase inhibitors |
|
162
|
613
|
4k2rA |
Structural basis for activation of zap-70 by phosphorylation of the sh2-kinase linker |
|
81
|
265
|
4kioA |
Kinase domain mutant of human itk in complex with a covalently-binding inhibitor |
|
81
|
272
|
4kaoA |
Focal adhesion kinase catalytic domain in complex with 1-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea |
|
11
|
57
|
4jjbA |
Crystal structure of the abl-sh3 domain at ph3 |
|
86
|
302
|
4ivdA |
Jak1 kinase (jh1 domain) in complex with compound 34 |
|
72
|
273
|
4id7A |
Ack1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol |
|
13
|
59
|
4hxjA |
Crystal structure of sh3:rgt complex |
|
88
|
290
|
4ji9A |
Jak2 kinase (jh1 domain) in complex with tg101209 |
|
11
|
58
|
4j9gA |
Crystal structure of the abl-sh3 domain complexed with the designed high-affinity peptide ligand p7 at ph7 |
|
90
|
302
|
4ivbA |
Jak1 kinase (jh1 domain) in complex with the inhibitor trans-4-{2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6h)-yl}cyclohexanecarbonitrile |
|
86
|
290
|
4i5cA |
The jak1 kinase domain in complex with inhibitor |
|
91
|
332
|
4hzsA |
Crystal structure of ack1 kinase domain with c-terminal sh3 domain |
|
89
|
300
|
4jiaA |
Jak2 kinase (jh1 domain) in complex with compound 9 |
|
10
|
56
|
4j9iA |
Crystal structure of the abl-sh3 domain complexed with the designed high-affinity peptide ligand p17 |
|
91
|
288
|
4i6qA |
Jak3 kinase domain in complex with 2-phenoxy-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((s)-1-cyclopropyl-ethyl)-amide |
|
12
|
63
|
4jjdA |
Crystal structure of the n114a abl-sh3 domain mutant at ph4 |
|
85
|
273
|
4i4eA |
Structure of focal adhesion kinase catalytic domain in complex with hinge binding pyrazolobenzothiazine compound. |
|
11
|
62
|
4j9fA |
Crystal structure of the abl-sh3 domain complexed with the high affinity peptide p0 |
|
10
|
58
|
4j9cA |
Crystal structure of the abl-sh3 domain h59q-n96t mutant complexed with the designed high-affinity peptide ligand p17 |
|
85
|
272
|
4i4fA |
Structure of focal adhesion kinase catalytic domain in complex with an allosteric binding pyrazolobenzothiazine compound. |
|
89
|
277
|
4i0tA |
Crystal structure of spleen tyrosine kinase complexed with 2-(5,6,7,8-tetrahydro-imidazo[1,5-a]pyridin-1-yl)-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide |
|
11
|
60
|
4jz4A |
Crystal structure of chicken c-src-sh3 domain: monomeric form |
|
10
|
58
|
4jjcA |
Crystal structure of the abl-sh3 domain at ph5 |
|
11
|
58
|
4j9bA |
Crystal structure of the abl-sh3 domain h59q-n96t mutant |
|
107
|
334
|
4ixpA |
Crystal structure of maternal embryonic leucine zipper kinase (melk) |
|
91
|
277
|
4i0sA |
Crystal structure of spleen tyrosine kinase complexed with 2-(6-chloro-1-methyl-1h-indazol-3-yl)-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide |
|
10
|
56
|
4j9eA |
Crystal structure of the n114a mutant of the abl-sh3 domain complexed with the high affinity peptide p17 |
|
6
|
57
|
4jz3A |
Crystal structure of the chicken c-src-sh3 domain intertwined dimer |
|
88
|
302
|
4ivcA |
Jak1 kinase (jh1 domain) in complex with the inhibitor (trans-4-{2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6h)-yl}cyclohexyl)acetonitrile |
|
92
|
277
|
4i0rA |
Crystal structure of spleen tyrosine kinase complexed with 2-(3,4,5-trimethoxy-phenyl)-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide |
|
10
|
59
|
4j9hA |
Crystal structure of the abl-sh3 domain complexed with the designed high-affinity peptide ligand p7 at ph 8 |
|
10
|
56
|
4j9dA |
Crystal structure of the n114a mutant of the abl-sh3 domain complexed with the high affinity peptide p0 |
|
92
|
292
|
4ivaA |
Jak2 kinase (jh1 domain) in complex with the inhibitor trans-4-[(8as)-2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(8ah)-yl]cyclohexanecarbonitrile |
|
85
|
273
|
4hzrA |
Crystal structure of ack1 kinase domain |
|
9
|
61
|
4hvwA |
Crystal structure of the t98e c-src-sh3 domain mutant in complex with the high affinity peptide vsl12 |
|
12
|
56
|
4hvvA |
Crystal structure of the t98e c-src-sh3 domain mutant in complex with the high affinity peptide app12 |
|
12
|
57
|
4hvuA |
Crystal structure of the t98d c-src-sh3 domain mutant in complex with the high affinity peptide app12 |
|
89
|
263
|
4hcuA |
Crystal structure of itk in complext with compound 40 |
